PTPI: Petros Pharmaceuticals Company Short-Term Debt

Symbol and logo of brand Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals is implementing digital services to optimize therapy and simplify medication access for patients. Due to pressure from generic alternatives, the company possesses limited pricing power, utilizing telemedicine to sustain demand. This chart of the market price on GURU.Markets, where the indicator stands at 0.00, complements the picture of a business relying on an aggressive sales department within the men's health segment.

PTPI (Petros Pharmaceuticals Inc) Company Short-Term Debts history from 07/04/2022 to 06/28/2025

Analytical breakdowns and data insights for company Petros Pharma (PTPI)

- current quotes and average value forecast:
Price Chart Petros Pharmaceuticals, Inc.|PTPI - Fair Value Consensus
- market capitalization information:
Market Value Petros Pharmaceuticals, Inc.|PTPI - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Petros Pharmaceuticals|PTPI - Book Capitalization|Market Cap to Net Assets Ratio petrospharma.com|PTPI - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Petros Pharmaceuticals|PTPI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Petros Pharmaceuticals|PTPI - Company Cumulative Indebtedness|Debts to Book Capitalization Petros Pharmaceuticals, Inc.|PTPI - Company Long-Term Loans and Borrowings|Company Short-Term Debts Petros Pharmaceuticals|Quick Liquidity petrospharma.com
- net income and valuation multiples indicators:
PTPI - Final Profit
Summary company analytics:Petros Pharmaceuticals, Inc. (PTPI)
Mass-produced product of petrospharma.com

This indicator captures the total volume of credit obligations due within a year, which determines the current liquidity and financial risk of the business. By analyzing short-term financial liabilities, an investor assesses the resilience of Petros Pharmaceuticals (PTPI) to market shocks, which is critical given the intense price competition from generics and the dependence on branding costs.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Tectonic Therapeutic TECX|TNXP (Tonix Pharma) - Current Liabilities|SXT China - Company Short-Term Debts|Short-Term Debt Eupraxia Pharmaceuticals|BHST (BioHarvest Sciences) - Company Current Liabilities|EXOZ: Amount of Current Liabilities|Company Short-Term Debt Oramed|ENTX: Company Short-Term Loans and Borrowings|Company Short-Term Debt MindWalk (HYFT)|ABVC - Short-Term Debt|Company Short-Term Debt Cumberland Pharmaceuticals CPIX|Short-Term Debt Volume quantumbiopharma.com (QNTM)|FGEN: Company Current Liabilities|Company Short-Term Loans and Borrowings TELO (Telomir Pharmaceuticals Inc)|ranitherapeutics.com (RANI) - Company Short-Term Debt|Current Liabilities SNYR (Synergy CHC)|RLYB (Rallybio Corp) - Company Short-Term Debts|LEXX: Company Short-Term Loans and Borrowings|Company Short-Term Debts PULM|Company Short-Term Debts ftzy.com.cn (PTHL)|Company Short-Term Debt Aptorum Group APM|Company Short-Term Loans and Borrowings LYRA|IBO - Company Short-Term Debt|TNF Pharmaceuticals (TNFA) - Company Current Liabilities|YCBD: Company Short-Term Debts|PainReform Ltd (PRFX) - Company Short-Term Debts|CYTO (Altamira Therapeutics Ltd) - Company Short-Term Debts|Company Current Liabilities Lipella Pharma (LIPO)|Company Short-Term Debts OPTN|PIRS - Short-Term Debt|Procaps - Company Current Liabilities|Company Short-Term Debts Qilian International Holding Group QLI|SLRN: Company Current Liabilities|TFF Pharmaceuticals, Inc - Amount of Current Liabilities